Epigenetic Biomarkers in Colorectal Cancer Patients Receiving Adjuvant or Neoadjuvant Therapy: A Systematic Review of Epidemiological Studies

Colorectal cancer (CRC) represents the third-most common cancer worldwide and one of the main challenges for public health. Despite great strides in the application of neoadjuvant and adjuvant therapies for rectal and colon cancer patients, each of these treatments is still associated with certain a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barchitta, Martina, Maugeri, Andrea, Li Destri, Giovanni, Basile, Guido, Agodi, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696286/
https://www.ncbi.nlm.nih.gov/pubmed/31390840
http://dx.doi.org/10.3390/ijms20153842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696286/
https://www.ncbi.nlm.nih.gov/pubmed/31390840
http://dx.doi.org/10.3390/ijms20153842

Ejemplares similares